Media-ID #9db61888
One focus of the development partnership with Randox is the implementation of a high-multiplex test for sepsis on the Vivalytic analysis platform. The sepsis test is to be implemented for the first time on the basis of the highly innovative and novel BioMEMS technology developed by Bosch Research in Renningen and Bosch Healthcare Solutions in Waiblingen. The powerful BioMEMS chip adds another innovative analysis method to the Vivalytic test cartridge and enables simultaneous and significantly faster testing for a large number of different pathogens.
Reproduction for press purposes free of charge with credit “Picture: Bosch”.